Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
359.5000 -2.65 (-0.73%)
NSE Sep 23, 2025 15:31 PM
Volume: 836.7K
High vol. this week

logo
Biocon Ltd.
13 Jan 2025
359.50
-0.73%
Motilal Oswal
Biocon (BIOS) has received ‘Voluntary Action Indicated’ (VAI) status for its Malaysian site. With this, BIOS now has all critical sites for biosimilars under USFDA compliance, improving its business prospects in the US market.
Number of FII/FPI investors increased from 305 to 333 in Jun 2025 qtr.
More from Biocon Ltd.
Recommended